Before revision:  We further validate DKT in two situations: (1) on synthetic data , showing that it can accurately estimate the ground truth parameters and (2) on 20 DTI scans from controls and PCA patients, showing that it has favourable predictive performance compared to standard approaches .
After revision:  We further validate DKT in two situations: (1) on synthetic data , showing that it can accurately estimate the ground truth parameters in the simulation and predict unseen biomarkers on the two patient datasets .